ADIL·00688A106·UQ·equity·Healthcare - Biotechnology-13D/G
ADIL (Adial Pharmaceuticals, Inc) is held by 14 institutional investors as of Q4 2025. Largest holders: CITADEL ADVISORS LLC ($48,317), VANGUARD GROUP INC ($34,325), GEODE CAPITAL MANAGEMENT, LLC ($34,263). Net institutional sentiment: Bullish.
See how ADIL's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer